Global Blood Therapeutics Inc is a company in the U.S. stock market and it is a holding in 39 U.S.-traded ETFs. GBT has around 3.9M shares in the U.S. ETF market. The largest ETF holder of GBT is the SPDR S&P Biotech ETF (XBI), with approximately 878.32K shares. Investors may also find of interest that the ETF with the largest allocation to GBT stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 4.52%. On average, U.S. ETFs allocate 0.42% of GBT to their portfolios.
Additionally, GBT is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with GBT as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 21.51%.